Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli.

    Frezza M, Yang H, Dou QP.

    J Cell Physiol. 2011 Nov;226(11):2731-9. doi: 10.1002/jcp.22758.

    PMID:
    21448923
    [PubMed - indexed for MEDLINE]
    2.

    mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.

    Bhutia SK, Das SK, Kegelman TP, Azab B, Dash R, Su ZZ, Wang XY, Rizzi F, Bettuzzi S, Lee SG, Dent P, Grant S, Curiel DT, Sarkar D, Fisher PB.

    J Cell Physiol. 2012 May;227(5):1805-13. doi: 10.1002/jcp.22904.

    PMID:
    21732348
    [PubMed - indexed for MEDLINE]
    3.

    Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells.

    Sivanandam A, Murthy S, Chinnakannu K, Bai VU, Kim SH, Barrack ER, Menon M, Reddy GP.

    J Cell Physiol. 2011 Jul;226(7):1889-96. doi: 10.1002/jcp.22516.

    PMID:
    21506119
    [PubMed - indexed for MEDLINE]
    4.

    Embryonal carcinoma cell induction of miRNA and mRNA changes in co-cultured prostate stromal fibromuscular cells.

    Vêncio EF, Pascal LE, Page LS, Denyer G, Wang AJ, Ruohola-Baker H, Zhang S, Wang K, Galas DJ, Liu AY.

    J Cell Physiol. 2011 Jun;226(6):1479-88. doi: 10.1002/jcp.22464.

    PMID:
    20945389
    [PubMed - indexed for MEDLINE]
    5.

    Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: role of Golgi apparatus.

    Fabbri F, Zoli W, Carloni S, Ulivi P, Arienti C, Brigliadori G, Montanari M, Tesei A, Silvestrini R, Amadori D.

    J Cell Physiol. 2011 Nov;226(11):3035-42. doi: 10.1002/jcp.22654.

    PMID:
    21302303
    [PubMed - indexed for MEDLINE]
    6.

    Error occurred: cannot get document summary

    PMID:
    21069721

    7.

    Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.

    Davis JN, Rogers D, Adams L, Yong T, Jung JS, Cheng B, Fennell K, Borazanci E, Moustafa YW, Sun A, Shi R, Glass J, Mathis JM, Williams BJ, Meyers S.

    J Cell Physiol. 2010 Nov;225(3):875-87.

    PMID:
    20607802
    [PubMed - indexed for MEDLINE]
    8.

    Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

    Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.

    J Cell Physiol. 2011 May;226(5):1334-9. doi: 10.1002/jcp.22461.

    PMID:
    20945400
    [PubMed - indexed for MEDLINE]
    9.

    Leptin increases motility and integrin up-regulation in human prostate cancer cells.

    Huang CY, Yu HS, Lai TY, Yeh YL, Su CC, Hsu HH, Tsai FJ, Tsai CH, Wu HC, Tang CH.

    J Cell Physiol. 2011 May;226(5):1274-82. doi: 10.1002/jcp.22455.

    PMID:
    20945385
    [PubMed - indexed for MEDLINE]
    10.

    CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway.

    Kuo PL, Chen YH, Chen TC, Shen KH, Hsu YL.

    J Cell Physiol. 2011 May;226(5):1224-31. doi: 10.1002/jcp.22445.

    PMID:
    20945384
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk